Role of oxidised low density lipoprotein in atherogenesis
Data up to Jan 2025
Total Citations Per Year
Abstract
References (79)
Beyond Cholesterol
1989 • 6,533 citations
Role of oxidized low density lipoprotein in atherogenesis.
1991 • 2,691 citations
Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition
1979 • 2,458 citations
The role of lipid peroxidation and antioxidants in oxidative modification of LDL
1992 • 2,335 citations
Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man.
1989 • 1,914 citations
Continuous Monitoring ofin VztroOxidation of Human Low Density Lipoprotein
1989 • 1,824 citations
Personal communication
2024 • 1,688 citations
Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids.
1984 • 1,631 citations
Low density lipoprotein undergoes oxidative modification in vivo.
1989 • 1,537 citations
Autoantibody against oxidised LDL and progression of carotid atherosclerosis
1992 • 1,332 citations
Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells.
1990 • 1,147 citations
Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit.
1987 • 1,051 citations
Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: recognition by receptors for acetylated low density lipoproteins.
1981 • 1,037 citations
Minimally modified low density lipoprotein stimulates monocyte endothelial interactions.
1990 • 930 citations
Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia.
1987 • 885 citations
Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions.
1991 • 879 citations
Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins
1990 • 871 citations
High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein
1990 • 836 citations
Endothelial and smooth muscle cells alter low density lipoprotein in vitro by free radical oxidation.
1984 • 826 citations
Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified low-density lipoproteins
1990 • 785 citations
Malondialdehyde-Altered Protein Occurs in Atheroma of Watanabe Heritable Hyperlipidemic Rabbits
1988 • 757 citations
Monocyte transmigration induced by modification of low density lipoprotein in cocultures of human aortic wall cells is due to induction of monocyte chemotactic protein 1 synthesis and is abolished by high density lipoprotein.
1991 • 739 citations
Involvement of the immune system in human atherogenesis: current knowledge and unanswered questions.
1991 • 669 citations
Probucol inhibits oxidative modification of low density lipoprotein.
1986 • 633 citations
Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein.
1990 • 627 citations
Ubiquinol-10 is an effective lipid-soluble antioxidant at physiological concentrations.
1990 • 621 citations
Lipoprotein (a). Heterogeneity and biological relevance.
1990 • 587 citations
Vitamin C Intake and Mortality among a Sample of the United States Population
1992 • 563 citations
Lipoproteins and Atherogenesis
1990 • 549 citations
Iron and copper promote modification of low density lipoprotein by human arterial smooth muscle cells in culture.
1984 • 547 citations
Impaired muscarinic endothelium-dependent relaxation and cyclic guanosine 5'-monophosphate formation in atherosclerotic human coronary artery and rabbit aorta.
1987 • 534 citations
LDL-induced cytotoxicity and its inhibition by HDL in human vascular smooth muscle and endothelial cells in culture
1979 • 512 citations
A macrophage receptor that recognizes oxidized low density lipoprotein but not acetylated low density lipoprotein
1989 • 480 citations
Decrease in reactive amino groups during oxidation or endothelial cell modification of LDL. Correlation with changes in receptor-mediated catabolism.
1987 • 473 citations
The role of sulfur-containing amino acids in superoxide production and modification of low density lipoprotein by arterial smooth muscle cells.
1987 • 465 citations
Low density lipoprotein rich in oleic acid is protected against oxidative modification: implications for dietary prevention of atherosclerosis.
1990 • 461 citations
A role for endothelial cell lipoxygenase in the oxidative modification of low density lipoprotein.
1989 • 417 citations
Modification of human serum low density lipoprotein by oxidation — Characterization and pathophysiological implications
1987 • 400 citations
Effects of oleate-rich and linoleate-rich diets on the susceptibility of low density lipoprotein to oxidative modification in mildly hypercholesterolemic subjects.
1993 • 390 citations
Essential role of phospholipase A2 activity in endothelial cell-induced modification of low density lipoprotein.
1985 • 388 citations
Presence of a modified low density lipoprotein in humans.
1988 • 373 citations
The antioxidant butylated hydroxytoluene protects against atherosclerosis.
1991 • 362 citations
Initiation of atherosclerotic lesions in cholesterol-fed rabbits. II. Selective retention of LDL vs. selective increases in LDL permeability in susceptible sites of arteries.
1989 • 339 citations
Feasibility of using an oleate-rich diet to reduce the susceptibility of low-density lipoprotein to oxidative modification in humans
1991 • 323 citations
Stimulation of Collagen Gene Expression by Ascorbic Acid in Cultured Human Fibroblasts
1989 • 312 citations
Enzymatic modification of low density lipoprotein by purified lipoxygenase plus phospholipase A2 mimics cell-mediated oxidative modification
1988 • 301 citations
Physiologic levels of ascorbate inhibit the oxidative modification of low density lipoprotein
1990 • 297 citations
Specificity of receptor-mediated recognition of malondialdehyde-modified low density lipoproteins.
1982 • 279 citations
Serum antibodies to oxidized low-density lipoprotein and ceroid in chronic periaortitis.
1990 • 266 citations
Antioxidant treatment of diabetic rats inhibits lipoprotein oxidation and cytotoxicity.
1989 • 265 citations
Direct evidence for a protein recognized by a monoclonal antibody against oxidatively modified LDL in atherosclerotic lesions from a Watanabe heritable hyperlipidemic rabbit.
1989 • 250 citations
Antioxidants in the prevention of human atherosclerosis. Summary of the proceedings of a National Heart, Lung, and Blood Institute Workshop: September 5-6, 1991, Bethesda, Maryland.
1992 • 247 citations
Plasma Vitamins E and A Inversely Correlated to Mortality from Ischemic Heart Disease in Cross‐Cultural Epidemiology
1989 • 240 citations
Oxidation of low-density lipoprotein by thiol compounds leads to its recognition by the acetyl LDL receptor
1987 • 236 citations
Minimally oxidized low-density lipoprotein induces tissue factor expression in cultured human endothelial cells.
1991 • 228 citations
Role of superoxide in endothelial-cell modification of low-density lipoproteins
1988 • 228 citations
Preservation of the endogenous antioxidants in low density lipoprotein by ascorbate but not probucol during oxidative modification.
1991 • 228 citations
Evidence for a dominant role of lipoxygenase(s) in the oxidation of LDL by mouse peritoneal macrophages
1991 • 223 citations
Macrophage colony-stimulating factor mRNA and protein in atherosclerotic lesions of rabbits and humans.
1992 • 219 citations
Macrophage-derived foam cells freshly isolated from rabbit atherosclerotic lesions degrade modified lipoproteins, promote oxidation of low-density lipoproteins, and contain oxidation-specific lipid-protein adducts.
1991 • 219 citations
Low density lipoprotein is protected from oxidation and the progression of atherosclerosis is slowed in cholesterol-fed rabbits by the antioxidant N,N'-diphenyl-phenylenediamine.
1992 • 207 citations
Effect of vitamin C and E supplementation on susceptibility of plasma lipoproteins to peroxidation induced by acute smoking
1990 • 205 citations
Effects of native and oxidized low density lipoproteins on formation and inactivation of endothelium-derived relaxing factor.
1991 • 190 citations
Immunohistochemical localization of the terminal C5b-9 complement complex in human aortic fibrous plaque
1985 • 183 citations
Recognition of solubilized apoproteins from delipidated, oxidized low density lipoprotein (LDL) by the acetyl-LDL receptor.
1987 • 171 citations
Effects of oxidatively modified LDL on cholesterol esterification in cultured macrophages.
1990 • 162 citations
Oxidized low density lipoproteins potentiate vasoconstrictions to various agonists by direct interaction with vascular smooth muscle.
1990 • 152 citations
Oxidized low density lipoprotein suppresses the expression of tumor necrosis factor-alpha mRNA in stimulated murine peritoneal macrophages.
1990 • 150 citations
Probucol attenuates the development of aortic atherosclerosis in cholesterol‐fed rabbits
1989 • 142 citations
Evidence for a concerted reaction between lipid hydroperoxides and polypeptides.
1992 • 115 citations
Attenuation of atherosclerosis in a modified strain of hypercholesterolemic Watanabe rabbits with use of a probucol analogue (MDL 29,311) that does not lower serum cholesterol.
1991 • 106 citations
The influence of oxidatively modified low density lipoproteins on expression of platelet-derived growth factor by human monocyte-derived macrophages
1991 • 102 citations
Lipoprotein-mediated inhibition of endothelial cell production of platelet-derived growth factor-like protein depends on free radical lipid peroxidation.
1987 • 87 citations
Modified forms of low density lipoprotein affect platelet aggregation
1989 • 74 citations
Differences in the metabolism of oxidatively modified low density lipoprotein and acetylated low density lipoprotein by human endothelial cells: inhibition of cholesterol esterification by oxidatively modified low density lipoprotein.
1989 • 64 citations
Evidence for an additional intracellular site of action of probucol in the prevention of oxidative modification of low density lipoprotein. Use of a new water-soluble probucol derivative.
1992 • 57 citations
Enhanced procoagulatory activity (PCA) of human monocytes/macrophages after in vitro stimulation with chemically modified LDL
1989 • 56 citations
Macrophages form circular zones of very close apposition to lgG‐Coated surfaces
1990 • 47 citations
Arterial Metabolism of Lipoproteins in Relation to Atherogenesis
1990 • 46 citations